AL
REZI icon

Aspiriant LLC’s Resideo Technologies REZI Stock Holding History

Aspiriant LLC’s Portfolio REZI Stock Details REZI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,900
Closed -$212K – 328
2025
Q3 		$212K Buy
+4,900
New +$153K 0.01% 291

Other funds holding REZI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aspiriant LLC's REZI Position: Q4 2025 in Review

Aspiriant LLC sold out of Resideo Technologies (REZI) in Q4 2025, closing a stake of 4,900 shares — an estimated $212K sold.

Aspiriant LLC first reported a position in REZI in Q3 2025 and held it in 1 quarter. The position peaked at $212K in Q3 2025. 448 funds tracked by Wall St. Rank hold REZI as of Q4 2025.

  • Aspiriant LLC reported no remaining Resideo Technologies position as of Q4 2025 after selling out during the quarter.
  • Aspiriant LLC sold 4,900 Resideo Technologies shares in Q4 2025, an estimated $212K.
  • Aspiriant LLC first reported a position in Resideo Technologies in Q3 2025 and held it in 1 quarter.
  • Aspiriant LLC's Resideo Technologies position peaked at $212K in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Resideo Technologies as of Q4 2025.

Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.